B

BLLN

BillionToOne, Inc.
HealthcareMedical - Diagnostics & Research|NASDAQ Global Select|US

Price

$79.36

Market Cap

$3.65B

Beta

6.30

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+99.97%
EPS Growth (YoY)+103.79%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio
FCF Yield+0.43%
Debt / Equity0.23
Interest Coverage168.7x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for BLLN.

BLLN — BillionToOne, Inc. Stock Analysis | Tessera Alpha